Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
| Status: | Terminated |
|---|---|
| Conditions: | Brain Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 22 - Any |
| Updated: | 3/29/2019 |
| Start Date: | September 1, 2017 |
| End Date: | March 25, 2019 |
The purpose of this study is to investigate if the potential biomarkers identified could be
used for facilitating the diagnosis and prognosis of patients with glioblastoma (GBM).
used for facilitating the diagnosis and prognosis of patients with glioblastoma (GBM).
The objective of this proposed study is to determine the expression levels of a panel of
markers including CD133, CD44, ABCC3, TNFRSF1A, AKT1, IDH2, and MGMT in GBM tissues and the
CSF, blood, and saliva from patients with GBM receiving different types of treatment (Optune
only or Optune with TMZ) and the non-brain tumor patients (controls). Our aims are: 1) To
compare the differences of CD44 between the control group and the combined cancer groups at
baseline; and 2) To compare the levels of CD44 and other markers among the 3 different groups
such as control vs. GBM patients and Optune vs. Optune + TMZ after 8 weeks of treatment.
Exploratory analysis of all other markers will be performed.
markers including CD133, CD44, ABCC3, TNFRSF1A, AKT1, IDH2, and MGMT in GBM tissues and the
CSF, blood, and saliva from patients with GBM receiving different types of treatment (Optune
only or Optune with TMZ) and the non-brain tumor patients (controls). Our aims are: 1) To
compare the differences of CD44 between the control group and the combined cancer groups at
baseline; and 2) To compare the levels of CD44 and other markers among the 3 different groups
such as control vs. GBM patients and Optune vs. Optune + TMZ after 8 weeks of treatment.
Exploratory analysis of all other markers will be performed.
Inclusion Criteria:
- 22 years old
- Control Group (only patients evaluated for neurological disorders whose evaluation
require a lumbar puncture)
- Non-Control Group - Diagnosed with GBM (Glioblastoma)
Exclusion Criteria:
- Pregnancy
- Infectious Disease to include cold, flu, HIV, etc.
- Blood Disorder (example:low platelets, anemia, thrombosis)
- Vascular Malformations
We found this trial at
1
site
2401 South 31st Street
Temple, Texas 76508
Temple, Texas 76508
Phone: 254-724-5939
Click here to add this to my saved trials
